Pricey Hepatitis Drug a Good Bet in U.S. Prisons, Study Says

October 21, 2014 12:54 AM

4 0

MONDAY, Oct. 20, 2014 (HealthDay News) -- Using an expensive drug to treat prison inmates with hepatitis C is more cost-effective than another treatment option, according to a new study.

More than 500,000 prison inmates in the United States have hepatitis C, which causes liver damage. It's spread by contact with infected blood.

Also read: U.S. has few good options for response to Philippines' Duterte

Read more

To category page